Today's Topline - 4/1/20

Wednesday, April 1, 2020

Source: MedTech Association

Today’s numbers continue to show an alarming rise in positive COVID-19 cases and resulting deaths.  Health experts agree that we remain firmly in the upward swing of the disease’s progression.  In a bit of promising news, however, our partners at AdvaMed released information about the bio/med industry’s herculean efforts to increase the availability of COVID-19 testing. Within the last few weeks, 17 diagnostics companies have received FDA Emergency Use Authorizations (EUA) and are rapidly scaling up testing capacity.   This has happened in a matter of days since the first commercial IVD for the coronavirus received FDA authorization on March 12, thanks to the fast work of many of our member companies and the FDA.

Hundreds of thousands of COVID-19 tests have been performed. Millions are now available, including several point-of-care tests that provide results in under an hour, and one that takes just five minutes. By mid-April, monthly capacity for commercial COVID-19 tests will be in the tens of millions. It’s an incredible accomplishment.

Tests that have received EUAs from FDA for COVID-19 include:

Additional COVID-19 IVDs that are available and being performed around the country, and in the process of securing EUAs, include:

MedTech exists to deliver value to the bio/med industry and serve those on the front lines of healthcare advances.  We rely on our members to make that possible.  Please take a moment to join or renew your membership today.  Renewing members can lock in last year’s rate through 2021.  New members who join today will receive 3 free months on their membership year.  Don’t wait.  We need your support to continue the work we do.

As always, don’t hesitate to contact us with your specific questions and concerns. Regular updates can be found at our website, which is refreshed daily.

View All News »